• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Cancer Therapeutics

Cancer Therapeutics

  1. Global Lung Cancer Vaccine Market & Pipeline Outlook 2022 - Research and Markets

    Global Lung Cancer Vaccine Market & Pipeline Outlook 2022 - Research and Markets

  2. VetDC Receives FDA Conditional Approval of TANOVEA™-CA1, the First New Animal Drug for Treating Lymphoma in Dogs

    VetDC Receives FDA Conditional Approval of TANOVEA™-CA1, the First New Animal Drug for Treating Lymphoma in Dogs

  3. ImmunoGen Announces Webcast of Presentation and Q&A at the 35th Annual J. P. Morgan Healthcare Conference

    ImmunoGen Announces Webcast of Presentation and Q&A at the 35th Annual J. P. Morgan Healthcare Conference

  4. Batu Biologics Welcomes Three Visionary Leaders to Its Newly Formed Clinical Advisory Board

    Batu Biologics Welcomes Three Visionary Leaders to Its Newly Formed Clinical Advisory Board

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.